Osterweis Capital Management »

Bridgebio Pharma shares owned by Osterweis Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Osterweis Capital Management from 13F filings

Historical chart of Osterweis Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Osterweis Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Osterweis Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 89k 40.37

More positions owned by Osterweis Capital Management

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Target Corporation (TGT)
Air Products & Chemicals (APD)
SYSCO Corporation (SYY)
Ross Stores (ROST)
Analog Devices (ADI)
Visa Com Cl A (V)
Waste Connections (WCN)
Progressive Corporation (PGR)
EastGroup Properties (EGP)
Becton, Dickinson and (BDX)
Lamar Advertising Cl A (LAMR)
Union Pacific Corporation (UNP)

View all positions for Osterweis Capital Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma